Overcoming tragedies, illness, and multiple production delays in 2022, R. J. Windham sets his compass north towards optimism as he invites you to join him as he travels virtually across the globe to meet incredible people that will help you and other prostate cancer patients navigate your own recovery adventure! 

Season One / Episode Eight The Patient-to-Patient Podcast

A Patient's Amazing Adventure!

For today's final adventure for Season One, we travel to the Continent of Europe and then to the Continent of North America to meet an "extraordinary person," fellow prostate cancer patient and now survivor Alex Lamb. 

Alex Lamb, Prostate Cancer Survivor

Alex Lamb's Adventure

After the death of his wife, Alex Lamb chose to leave the United Kingdom and emigrate to the United States to live with one of his sons. As per protocol, a series of tests were ordered by his doctor to comply with the rules of emigrating to his new country. In 2018, his PSA (Prostate Specific Antigen) scores spiked from 2.5 up to 9.5. His Urologist confirmed his cancer diagnosis in May of 2018 at the age of 79 years old. After thirty-six straight weekdays of treatments, Alex credits his survival to the luck of emigrating to the USA, his Urologist, and to Boston Scientific for developing the SpaceOAR Hydrogel procedure.

Main Topics Discussed

1. How Emigrating To The USA Saved His Life The Market?
2. Alex Participates In An Experimental Procedure
3. Active In Jogging, Karate, Yoga
4. Why He Is The "Luckiest" Man Alive

https://www.bostonscientific.com/en-US/Home.html

https://www.bostonscientific.com/en-US/products.html

https://www.bostonscientific.com/en-US/products/hydrogel-spacers/spaceoar-hydrogel.html

https://www.bostonscientific.com/en-US/medical-specialties/urology/prostate-health/prostate-cancer/spaceoar-hydrogel.html

www.rjwindham.com

Season One / Episode Seven The Patient-to-Patient Podcast

Fewer Sexual Issues?

For today's adventure, we travel to the Continent of North America, specifically to the United States, to meet Ronald A. Morton, JR, MD, the Chief Medical Officer of the Urology and Pelvic Health division of Boston Scientific. Dr. Ron and I discussed a procedure pioneered by Boston Scientific and one I was unaware of before my prostatectomy. I know that you will enjoy meeting Dr. Morton. Perhaps after listening to our discussion, this procedure utilizing SpaceOAR Hydrogel may be an option for you.

Dr. Ronald Morton Jr

Dr. Mortons Bio Doctor of Physical Therapy, Sexual Health Counselor, Sexual Health Educator

Ronald A. Morton, JR, MD, FACS, is the Chief Medical Officer of the Urology and Pelvic Health division of Boston Scientific. Before joining Boston Scientific via acquisition, Morton worked for Endo International plc as a chief surgical officer at American Medical Systems. Previously, he worked as a chief medical officer for GTx, a biotech company in Memphis, TN. Before joining GTx, Morton was chief of urology at Robert Wood Johnson Medical School and director of urologic oncology for the Cancer Institute of New Jersey. He also held an endowed chair position as director of the General Clinical Research Center. Morton holds a BA in natural sciences from The Johns Hopkins University and received his medical doctorate from The Johns Hopkins University School of Medicine. He has board certification as a diplomat, American Board of Urology.

Main Topics Discussed

1. What Is SpaceOAR Hydrogel, And When Did It First Come On The Market?
2. Complications From Radiation Avoided?
3. What Is The Risk Reward?
4. In what Countries Is This Option Available
5. How This Procedure Preserves Quality Of Life After Surgery
6. Other Products From Boston Scientific

https://www.bostonscientific.com/en-US/Home.html

https://www.bostonscientific.com/en-US/products.html

https://www.bostonscientific.com/en-US/products/hydrogel-spacers/spaceoar-hydrogel.html

https://www.bostonscientific.com/en-US/medical-specialties/urology/prostate-health/prostate-cancer/spaceoar-hydrogel.html

https://www.linkedin.com/in/ronald-morton-b6213211/